Supplementary Table 2: Signature genes; identified by allowing a group assignment of new CSC lines and using shrunken centroid classification to identify 29 transcripts encoding 24-signature genes  which discriminate between type I and type IIGBM CSC lines

Table 2. Selection of differentially regulated genes between fNSC (fetal neural stem cell) lines and type I GBM (Glioblastoma multiforme) CSC (cancer stem cell) lines

Table 1. Selection of differentially regulated genes between type I and type II GBM (Glioblastoma multiforme) CSC (cancer stem cell) lines

Table 3. Selection of differentially regulated genes between aNSC (adult neural stem cell) lines and type II GBM (Glioblastoma multiforme) CSC (cancer stem cell) lines

Additional file 3-GENIUS ER+/HER2- subtype signature

Additional file 3-GENIUS HER2+ subtype signature

Additional file 3-GENIUS ER-/HER2- subtype signature

Table 3. Selected non-redundant survival-significant gene pairs identified in both cohorts of breast cancer patients

Supplementary Table S1a. P values of Kolmogorov-Smirnov test of Normality in the Stockholm cohort for 5 genes in SFGM group (SFGM matrix) and 6 \neighbouring\" genes (NM - \"neighbours\" matrix)."

Supplementary Table S1b. P values of Kolmogorov-Smirnov test of Normality in the Uppsala cohort for 5 genes in SFGM group (SFGM matrix) and 6 \neighbouring\" genes (NM - \"neighbours\" matrix)."

Supplementary Table S1c. P values of Kolmogorov-Smirnov test of Normality in
 Stockholm cohort for 17 genes of ERBB2 amplicon on 17q12.

Supplementary Table S1d. P values of Kolmogorov-Smirnov test of Normality in the
 Uppsala cohort for 17 genes of the ERBB2 amplicon on 17q12.

Table 2. Individual genes selected among the TNFAIP1/POLDIP2 SFGM and 6 \neighbouring\" genes which proved to be survival significant in at least one cohort (P value ó 0.05)."

Table 2. Top 20 genes that were down-regulated by >0.5-fold in miR-145 transfectants in comparison with the control

Table 4. The 15 G protein coupled receptors (GPCRs) that exhibited the largest change in expression in day 4 EBs compared to undifferentiated ES cells. The data represent the average of the results from two independent experiments.